Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
278 Leser
Artikel bewerten:
(1)

FM Marketing LLC: Women's Cancer Center of Nevada Debuted New State-of-the-Art Headquarters

New $10 mil building will help improve care by shortening wait times, improving diagnoses and letting patients and physicians build stronger bonds

LAS VEGAS, NV / ACCESS Newswire / October 8, 2025 / Women's Cancer Center of Nevada (WCCN), the largest group of gynecologic oncologists in Nevada and the only one with a full-time research staff and open protocols that advance women's cancer science and treatment, debuted their new state-of-the-art headquarters in Las Vegas.

Women's Cancer Center of Nevada

Women's Cancer Center of Nevada
Exterior of Women's Cancer Center of Nevada's new headquarters

The new $10 mil building will help improve care by shortening wait times, improving diagnoses and letting patients and physicians build stronger bonds.

"This new locale will improve patient care in the short term by allowing more clinical trials, longer patient visits and in the longer term by attracting more top-flight doctors to serve our community," Spirtos said.

The medical building is the first newly constructed building in the Las Vegas Medical District since the opening of the Kirk Kerkorian UNLV School of Medicine in Oct. 2022.

Nevada Governor Joe Lombardo, Las Vegas Mayor Shelley Berkley and Councilman Brian Knudsen spoke about Women's Cancer Center of Nevada's impact in the Southern Nevada community during the ceremony.

Women's Cancer Center of Nevada occupies the entire second floor of the new three-story building. The building also houses Saguaro Surgical Center on the first floor and the Saguaro Medical Group occupying the third floor.

The center is running trials for several treatments involving up to 47 people. Some trials last months, some years and others continue indefinitely. This represents the highest number of clinical trials for women's cancers in the State of Nevada.

Spirtos founded the center in 1998 as a full-member research institution in the Gynecologic Oncology Group, a National Cancer Institute-sponsored co-operative. This connection has let the center and its patients tap research protocols generally available only outside of Nevada.

"Our surgeons are pioneers in research and ready for any challenge for both patients and their families," added Spirtos.

Over the years, The Women's Cancer Center of Nevada has grown to several doctors, including:

  • CEO, Founder Nick M. Spirtos, M.D.

  • Co-Founder, Director Geoffrey C. Hsieh, M.D.

  • Aimee C. Fleury, M.D., MPH

  • Natalie S. Gould, M.D.

  • Alexandra Spirtos, M.D.

Spirtos, the Nevada State Board of Medical Examiners' president since 2023, remains a fierce advocate for patient safety and has worked to increase Nevada's number of licensed physicians and medical care providers.

ABOUT WOMEN'S CANCER CENTER OF NEVADA

The Women's Cancer Center is a recognized leader in the fight against gynecological cancers including ovarian, breast and uterine cancer. As a full member in the Gynecologic Oncology Group, we offer both standard approaches and clinical trials for those who qualify. Visit https://wccenter.com/ to learn more about the center.

Contact Information

Susan Somers
Managing Member
susan@fmmpr.com
702-249-9900

.

SOURCE: FM Marketing LLC



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/publishing-and-media/womens-cancer-center-of-nevada-debuted-new-state-of-the-art-headquarters-1084285

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.